Tekla Capital Management - aVenture Asset Manager Research
Location
Boston, MA, US
Founded
1986
Tekla Capital Management is a Boston-based investment adviser specializing in the healthcare and life sciences sectors. The firm manages two closed-end equity funds, H&Q Healthcare Investors and H&Q Life Sciences Investors, focusing on growth equities in both public and private markets. Tekla typically invests in Series A through Series E rounds, with notable participation in Series B rounds.
Tekla's portfolio includes prominent companies such as Arbor Biotechnologies, Caribou Biosciences, and ReCode Therapeutics. The firm's investment philosophy emphasizes long-term growth and innovation within the healthcare and life sciences industries. Tekla's experienced team provides strategic guidance and industry expertise to its portfolio companies, leveraging their deep sector knowledge to drive value creation.
Tekla Capital Management - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages